Article Text
Statistics from Altmetric.com
Study design
Design:
randomised placebo controlled trial (Controlling Hypertension and Hypotension Immediately Post Stroke [CHHIPS] study).
Allocation:
concealed.*
Blinding:
blinded (patients and researchers).*
Study question
Setting:
6 centres in England, UK.
Patients:
179 patients >18 years of age with a fixed neurological deficit lasting >60 min, clinical diagnosis of suspected stroke, and symptom onset within 36 hours (depressor group) and hypertension (mean systolic blood pressure [BP] level >160 mm Hg). Exclusion criteria included current antihypertensive therapy in non-dysphagic patients, contraindications to trial therapy, and significant comorbidity or life expectancy <6 months. The pressor group (symptom onset <12 h and hypotension) had only 1 patient, was discontinued, and is not reported here.
Intervention:
lisinopril, 5–15 mg daily (n = 58), labetalol, 50–150 mg on day 1 then 100–300 mg …
Footnotes
-
Source of funding: National Institute for Health Research Health Technology Assessment Programme.